Supplements · Sweeteners · Metabolic & Cardiometabolic
stevia does not raise blood glucose
In plain terms: Is stevia safe for your blood sugar?
Part of: • Stevia
Yes - this is stevia's most solid benefit. Your body doesn't turn steviol glycosides into glucose, so stevia doesn't raise blood sugar, and swapping it in for sugar modestly lowers the post-meal glucose and insulin bump. A few of the studies are industry-linked, but the finding is uncontested and makes mechanistic sense.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Stevia is **blood-sugar-friendly**: steviol glycosides aren't absorbed intact or converted to glucose (gut bacteria cleave them to steviol, which is excreted), so stevia doesn't raise blood sugar — and when it replaces sugar it modestly *lowers* the post-meal glucose and insulin rise. This is well established and mechanistically clear, the clearest of stevia's health claims. Honest caveat: several
The evidence (8)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Gregersen S et al. 2004 · Metabolism | RCT | supports | moderate | Acute RCT (12 T2D): 1 g stevioside cut postprandial glucose iAUC 18% vs control; no rise. |
| Zare M et al. 2024 · Clin Nutr ESPEN | meta-analysis | supports | moderate | Meta-analysis of RCTs on stevia and glycemic indices: favorable/neutral glycemic profile, no glucose-raising effect. |
| Bundgaard Anker CC et al. 2019 · Nutrients | meta-analysis | supports | moderate | SR/meta of RCTs (T2D biomarkers): no adverse glucose-raising effect; some modest-benefit signal. |
| Almiron-Roig E et al. 2023 · Food Funct | RCT | supports | moderate | Crossover RCT (SWEET): stevia RebA reduced glucose iAUC vs sucrose (p<0.05), lower insulin iAUC. [industry-adjacent EU consortium funding] |
| Nunez Martinez P et al. 2016 · Nutr Hosp | mechanism | supports | low | Pharmacokinetic review: metabolic fate of rebaudioside A/stevioside consistent with a non-glycemic profile. |
| Angarita Davila L et al. 2017 · Nutrients | RCT | supports | low | Crossover RCT: stevia had lower glucose iAUC than control; no rise in postprandial insulin. |
| Magnuson BA et al. 2016 · Food Chem Toxicol | mechanism | supports | moderate | ADME review: steviol glycosides not absorbed intact, cleaved to steviol by gut bacteria, excreted - not converted to glucose. [Cargill-affiliated co-authors] |
| Stamataki NS et al. 2020 · Nutrients | RCT | supports | moderate | 12-wk RCT (healthy adults): daily stevia did not adversely affect glycemia; no rise in glucose-homeostasis markers. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.